581312753 | PUO | 77634248 | | 5932655 | 3/20/2006 12:00:00 AM | CHF exacerbation | | DIS | Admission Date: 3/27/2006 Report Status:

Discharge Date: 4/5/2006
****** FINAL DISCHARGE ORDERS ******
BONING , FREDDA F 207-67-77-5
Mer
Service: CAR
DISCHARGE PATIENT ON: 8/20/06 AT 05:00 PM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: KATCSMORAK , CARRI GARY , M.D.
CODE STATUS:
No CPR , No defib , No intubation
DISPOSITION: Home w/ services
DISCHARGE MEDICATIONS:
ACETYLSALICYLIC ACID 325 MG PO DAILY
Override Notice: Override added on 10/29/06 by
BOISER , ESTELL J. , M.D.
on order for COUMADIN PO ( ref # 178481090 )
POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN
Reason for override: aware
ALLOPURINOL 100 MG PO DAILY
Alert overridden: Override added on 10/29/06 by
BOISER , ESTELL J. , M.D.
SERIOUS INTERACTION: WARFARIN &amp; ALLOPURINOL
Reason for override: aware
TESSALON PERLES ( BENZONATATE ) 100 MG PO TID
Number of Doses Required ( approximate ): 20
NEXIUM ( ESOMEPRAZOLE ) 20 MG PO DAILY
FERROUS SULFATE 325 MG PO TID Starting Today ( 4/24 )
Food/Drug Interaction Instruction Avoid milk and antacid
GLIPIZIDE 5 MG PO BID
K-DUR ( KCL SLOW RELEASE ) 20 MEQ PO BID
As per PUO Potassium Chloride Policy:
each 20 mEq dose to be given with 4 oz of fluid
LEVOXYL ( LEVOTHYROXINE SODIUM ) 100 MCG PO DAILY
Alert overridden: Override added on 10/29/06 by
BOISER , ESTELL J. , M.D.
SERIOUS INTERACTION: WARFARIN &amp; LEVOTHYROXINE SODIUM
Reason for override: aware
ATIVAN ( LORAZEPAM ) 0.5 MG PO QPM PRN Insomnia
TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE )
100 MG PO DAILY Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
Number of Doses Required ( approximate ): 3
PRAVACHOL ( PRAVASTATIN ) 40 MG PO BEDTIME
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
Override Notice: Override added on 10/29/06 by
BOISER , ESTELL J. , M.D.
on order for MULTIVITAMIN THERAPEUTIC PO ( ref #
018429467 )
POTENTIALLY SERIOUS INTERACTION: PRAVASTATIN SODIUM &amp;
NIACIN , VIT. B-3 Reason for override: aware
Previous override information:
Override added on 10/29/06 by BOISER , ESTELL J. , M.D.
on order for COUMADIN PO ( ref # 178481090 )
POTENTIALLY SERIOUS INTERACTION: PRAVASTATIN SODIUM &amp;
WARFARIN Reason for override: aware
MULTIVITAMIN THERAPEUTIC ( THERAPEUTIC MULTIVI... )
1 TAB PO DAILY
Alert overridden: Override added on 10/29/06 by
BOISER , ESTELL J. , M.D.
POTENTIALLY SERIOUS INTERACTION: PRAVASTATIN SODIUM &amp;
NIACIN , VIT. B-3 Reason for override: aware
TORSEMIDE 80 MG PO BID Starting Today ( 4/24 )
COUMADIN ( WARFARIN SODIUM ) 1 MG PO QPM
Starting NOW ( 4/24 )
Instructions: WITHIN HOUR OF PHARMACY APPROVAL
Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Override Notice: Override added on 10/29/06 by
BOISER , ESTELL J. , M.D.
on order for ALLOPURINOL PO ( ref # 676820163 )
SERIOUS INTERACTION: WARFARIN &amp; ALLOPURINOL
Reason for override: aware Previous override information:
Override added on 10/29/06 by BOISER , ESTELL J. , M.D.
on order for LEVOXYL PO ( ref # 634337691 )
SERIOUS INTERACTION: WARFARIN &amp; LEVOTHYROXINE SODIUM
Reason for override: aware Previous override information:
Override added on 10/29/06 by BOISER , ESTELL J. , M.D.
on order for LEVOFLOXACIN PO ( ref # 675949597 )
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; LEVOFLOXACIN
POTENTIALLY SERIOUS INTERACTION: WARFARIN &amp; LEVOFLOXACIN
Reason for override: aware Previous override information:
Override added on 10/29/06 by BOISER , ESTELL J. , M.D.
POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN
POTENTIALLY SERIOUS INTERACTION: PRAVASTATIN SODIUM &amp;
WARFARIN Reason for override: aware
DIET: Patient should measure weight daily
DIET: House / Low chol/low sat. fat
DIET: House / ADA 1800 cals/dy
DIET: 2 gram Sodium
ACTIVITY: Walking as tolerated
FOLLOW UP APPOINTMENT( S ):
Dr. Coletta Verry 8/3/06 @ 11AM scheduled ,
Cardiology clinic for blood work ( Nessinee Ker Hospital Medical Center ) 11/1/06 ,
ALLERGY: NKA
ADMIT DIAGNOSIS:
CHF exacerbation
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
CHF exacerbation
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
congestive heart failure , coronary artery disease , hypertension , diabetes
mellitus , gastroesophageal reflux disease , hypothyroidism , mitral
regurgitation s/p repair , lung ca s/p lobectomy , endometrial ca s/p
TAH/BSO , basal cell carcinoma , chronic renal dysfunction , renal artery
stenosis s/p L stent , recurrent flash pulm edema
OPERATIONS AND PROCEDURES:
none
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
IV diuretics , electrolyte monitoring , antibiotics
BRIEF RESUME OF HOSPITAL COURSE:
CC: increasing SOB , weight gain
*****
HPI: Pt is a 75F with a h/o CHF/CAD , a-fib , lung CA s/p R wedge
resection. She has been admitted 5-6 times this year for CHF
exacerbation. She was discharged from the hospital on 3/4 after tx
for CHF and PNA and was followed by the CHF RN. Over the past 3 days
since discharge , she has noticed a 3lb weight gain. Additionally , pt
has had increasing SOB , poor sleep. Stable 2 pillow orthopnea but
more comfortable sitting bent over at the waist. Per her PCP's
instructions , pt increased Torsemide to 40mg BID which did not
increase her UOP.
ROS: +SOB +PND +orthopnea + bilat LE swelling , brief CP , + diarrhea
( 2 per day ) , no palpitations/dizziness.
*****
In ED: T95.6 P74 BP118/65 RR10 SaO2 on 98 on RA Pt received 40 Lasix IV.
***
Home Medications: 1. ASA 325 , Allopurinol 100 , Nexium 20 , Iron 325 MG
TID Glipizide 5 MG BID , K-dur 20 BID , Levoxyl 100 MCG , Lorazepam 0.5 MG
QD prn , Toprol Xl 100 MG , MVI , pravastatin 40 mg QHS , Torsemide 40 MG
BID , Coumadin 1 MG
***
Allergies: NKDA
****
PMH: CRI , hypothyroidism , paroxysmal a-fib , DM , CHF , CAD , lung CA s/p
R wedge resection , basal cell CA on lip s/p resection , uterine CA s/pTAH.
***
FHx: non contrib
***
Social: Lives with husband across street from KAAH .  +tob history ,
-EtOH , -IVDU
***
PE on admit: VS:T: 95.6 P74 BP:118/75 RR10 SaO2 100% on RA , JVP
15cm C/V irreg irreg , no m/g/r. Lungs crackles at R base. Legs
2+ LE edema. +tenderness on L shin/bruise , AAOx3 CXR: no pulm edema ,
improved RLL PNA
****
PE on Discharge - 97.7 P65-84 BP 90-108/50 RR18 93-97% on RA , A&amp;OX3 , more
solid stool , lungs CTA on left , decreased breath sounds on right , JVP
8cm , CV irreg irreg , 1+ lower extremity edema on R , 3+ on LLE
****
Studies: LENI 4/30 - negative for DVT in left lower extremity
C Diff negative
****
Hospital Course: 75F with h/o CAD/CHF/lung CA/Afib with 3 days of weight
gain , worsening SOB and orthopnea.
1 )CHF: Patient presented with symptoms of heart failure--PND , elevated
JVP and bilateral LE edema. No clinic evidence of acute coronary
syndrome. She was continued on her CAD regimen of BB , asa , statin. She
was diuresed , initially with lasix 40mg IV then 80mg IV with excellent
results--&gt;1L negative per day on a BID regimen. However , her weight
remained unchanged at 165lb. At time of discharge , she is continuing to
be net negative on po torsemide. She is discharged with torsemide 80mg
BID and will have close VNA and electrolyte follow-up. Dry weight
goal previously had been 155-157lb , but given the resolution in her
symptoms and overall clinical picture , she is discharged above her dry
weight with close follow-up.
2 ) Afib --continue coumadin 1mg , INR on discharge is 2.1
3 ) PNA- Recent RLL PNA for which she completed course of levofloxacin and
cefpodoxime. Diarrhea likely antibiotic associated , was negative for C
diff and responded to lactobacillus supplements.
4 ) Anemia: Chronic iron deficiency. HCT 28.7 but elected not to
transfuse. Continue iron supplement.
5 ) FEN- Pt was compliant with a 1.5L fluid restriction and &lt;2g salt
cardiac diabetic diet.
6 ) Diabetes - Was managed on lantus/novolog in house and will resume
oral DM meds on discharge. Continued Levoxyl 100meq. Recent TSH 8/22
wnl. Continue allopurinol for presumed gout.
ADDITIONAL COMMENTS: During this hospitalization you were treated for heart failure. You
should continue to monitor your diet and salt intake. We have increased
your diuretic dose to torsemide 80mg twice a day. Please have your blood
electrolytes checked in 2 days. If you have any chest pain , worsening
shortness of breath , or any other concerning symptom call your doctor or
go to the ER.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
1. VNA services for cardiopulmonary assessment , weight monitoring , heart
failure monitoring
2. She is discharged on torsemide 80 BID and will need her electrolytes
checked in 2 days.
3. Coumadin followed by Dr. Pidro with Flanda Medwan Rorael Memorial Hospital And Health Services
No dictated summary
ENTERED BY: BONEFONT , KEIRA B. , M.D. , PH.D. ( TK84 ) 8/20/06 @ 02:43 PM
****** END OF DISCHARGE ORDERS ******